BÜHLMANN Educational Workshop at EuroMedLab 2019
The BÜHLMANN Educational Workshop at EuroMedLab 2019, focused on optimizing workflow for fecal calprotectin testing was a great success. This workshop offered insightful presentations from three laboratories discussing the process of stool sample pre-analytics and how they worked to find a solution to cope with continuously increasing test numbers. State-of-the-art technologies combined with modern sample management strategies were the key to measure up to the challenge.
BÜHLMANN at EuroMedLab 2019
View videos from the EuroMedLab and the Educational Workshop presented by BÜHLMANN
Dr. Aleksandra Havelka (Sweden)
Laboratory Workflow Optimization in the Field of Fecal Calprotectin Testing
Dr. Luca Germagnoli (Italy)
Fecal Calprotectin in Modern Clinical Chemistry
Dr. Lukas Bestmann (Switzerland)
Full Automation – The Future Laboratory
Dr. Maurice Redondo (Switzerland)
BÜHLMANN fCAL® turbo (K190784): FDA 510(k) cleared. For in vitro Diagnostic Use.
BÜHLMANN fCAL® turbo + CALEX® Cap (K191718): FDA 510(k) cleared. For in vitro Diagnostic Use.
Health Canada Licenses: BÜHLMANN fCAL® turbo (96808), CALEX® Cap (98839)
BÜHLMANN fCAL® turbo currently has validated application notes for the Roche c501/502 for use in the U.S. Other major chemistry system validation packages are in process. Please contact BUHLMANN Diagnostics Corp for a complete list of validated applications.